Executive Summary
DOE dominates with $72B+ in nuclear security, lab management, and environmental cleanup contracts, mostly to private/non-profits, signaling long-term U.S. nuclear/renewable R&D priority but limited public equity exposure. NASA awards $7.5B+ across 15 contracts to space infrastructure leaders, affirming Artemis/SLS momentum with bullish reads for Boeing ($2.2B) and sector peers. Public govcon firms like Booz Allen ($1.1B across wins), Leidos ($953M), and Lockheed ($479M) capture $5B+ in IT, cyber, and aviation modernization, providing revenue visibility amid $0 base/options funding gaps.
Investment Signals(5)
- DOE Nuclear/Lab M&O Stability(HIGH)▲
Top 6 contracts total $71B for nuclear sites (Y-12/Pantex), labs (LBNL, NREL, PPPL, NNSS), mostly private/non-profit, underscoring sustained funding but no direct public plays.
- NASA Space Program Momentum(HIGH)▲
15 NASA contracts worth $7.5B+ validate SLS/Artemis (Boeing $2.2B, Blue Origin $1.7B, Bechtel $1.5B), range ops (KBR $548M+$224M), boosting space infrastructure demand.
- GovCon IT/Health Wins Accelerate(MEDIUM)▲
BAH secures $1.1B (VA $590M, GSA $400M, NSF $105M), Leidos $953M DOE research, plus GD IT $449M SEC, signaling civilian IT/cyber strength amid 10+ awards >$100M.
- Defense/Aviation Modernization(MEDIUM)▲
Lockheed $479M FAA NextGen, Northrop $321M CBP P-3, Gulfstream $172M Coast Guard aircraft highlight aviation sustainment/infrastructure spend.
- Non-Profit University Dominance(HIGH)▲
UC Regents $19B LBNL + $110M COSI, Princeton $2.1B PPPL limit equity upside despite $21B+ scale in DOE/NASA lab ops.
Risk Flags(3)
- Execution[HIGH RISK]▼
$0 base/options across 90%+ contracts + missing performance dates/location expose funding drawdown and timeline uncertainty in nuclear/space/IT scopes.
- Regulatory[MEDIUM RISK]▼
DOE/NNSA oversight in nuclear ops (Y-12/Pantex $32B, NNSS $7B) + CMS/VA healthcare rules amplify compliance hurdles.
- Competitive[MEDIUM RISK]▼
Private LLCs (Anduril $363M towers, Guidehouse $312M grants) win incumbency but face recompetes in IDIQ follow-ons.
Opportunities(3)
- ◆
NASA SLS/Artemis follow-ons (Boeing SPEC evolution, Blue Origin lander demos) + Wallops/KBR range ops could add $2B+ multi-year.
- ◆
DOE lab/ICP extensions (NREL renewables $10B, Idaho cleanup $1.3B) + civilian IT GWACs signal $10B+ pipeline in green/nuclear R&D.
- ◆
BAH/Guidehouse VA/DOI health/IT task orders ($590M+$312M) position for CMS modernization expansions.
Sector Themes(3)
- ◆
83% of value ($71B+) in DOE M&O for weapons labs, tritium, NREL signals decade-long funding stability despite private recipients.
- ◆
9% value ($7.5B) in SLS launcher/stages, landing systems, range ops underscores commercial space buildout.
- ◆
VA/GSA/SEC/CDC awards total $3B+ for data mod, cyber defend, networks highlight non-DoD govcon shift.
Watch List(4)
- 👁
{"entity"=>"Boeing (BA)", "reason"=>"$2.2B SLS stages is largest public co win; tracks Artemis delays.", "trigger"=>"SLS launch schedule updates"}
- 👁
{"entity"=>"Booz Allen (BAH)", "reason"=>"3 wins total $1.1B in health/IT; 2%+ of annual revenue.", "trigger"=>"Q1 FY26 bookings beat"}
- 👁
{"entity"=>"DOE Nuclear Private LLCs (CNS, Mission Support)", "reason"=>"$39B combined; potential M&A targets.", "trigger"=>"ownership changes or public listings"}
- 👁
{"entity"=>"NASA Artemis Supply Chain", "reason"=>"Blue Origin/Bechtel/KBR wins signal tier-2 growth.", "trigger"=>"ML2 launcher delivery milestones"}
Get daily alerts with 5 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 41 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC